Clinical Trial Update: Lantus Effect on Myocardial Glucose Metabolism in T2 [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating insulin glargine (Lantus) and its effect on myocardial glucose metabolism in type 2 diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Lantus (insulin glargine)

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED